Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report)’s share price was down 3.8% on Wednesday . The company traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares changed hands during trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Trading Down 3.8 %
The company has a current ratio of 2.97, a quick ratio of 2.61 and a debt-to-equity ratio of 35.45. The stock has a market capitalization of C$52.28 million and a P/E ratio of -0.37. The company has a 50-day moving average price of C$0.26 and a 200 day moving average price of C$0.26.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Featured Stories
- Five stocks we like better than Emerald Health Therapeutics
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- What is Put Option Volume?
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- The Significance of Brokerage Rankings in Stock Selection
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
